Neurons from stem cells could replace mice in botulinum test

Feb 06, 2012

(PhysOrg.com) -- Using lab-grown human neurons, researchers from the University of Wisconsin-Madison have devised an effective assay for detecting botulinum neurotoxin, the agent widely used to cosmetically smooth the wrinkles of age and, increasingly, for an array of medical disorders ranging from muscle spasticity to loss of bladder control.

The new assay uses neurons, the critical impulse conducting cells of the , derived from induced . It is the first test to employ stem cell derivatives to reliably and quantitatively detect and the antibodies that can neutralize the toxin's effects.

The assay is likely to draw considerable interest from industry as a potential replacement for the mouse, an animal now used by the thousands to control the potency of pharmaceutical preparations of the powerful neurotoxin.

Using cells provided by Madison-based Cellular Dynamics International, a company that industrially manufactures induced pluripotent and their derivative for use in research and industry, the University of Wisconsin-Madison team devised an assay that is more sensitive than the mouse assay required for quality control of pharmaceutical preparations of botulinum toxin.

"This is an optimal testing platform for botulinum neurotoxin products," explains Sabine Pellett who, with UW-Madison professor of bacteriology Eric A. Johnson, led the new study published this week in the journal Toxicological Sciences. "A cell-based assay that is at least as sensitive and reproducible as the mouse bioassay can serve as a viable alternative and largely eliminate the need to use animals."

The toxin is used most famously for cosmetic purposes to erase the that come with age. However, it is also used in a growing number of medical applications. Since it was first approved in 1990 for use in human patients with or cross-eye, the toxin, which works by blocking communication between nerves and muscles, has been used to successfully treat excessive sweating, chronic migraine headaches, painful neck spasms known as dystonia, and muscle conditions associated with cerebral palsy, multiple sclerosis and stroke. In 2010, the Food and Drug Administration (FDA) approved the toxin for use in treating loss of bladder control. Pharmaceutical applications of the toxin underpin a market that easily exceeds $1 billion annually.

Botulinum toxin is a protein produced by the bacterium Clostridium botulinum. It is the most potent toxin known to science and before its first experimental medical application to treat cross-eye was best known as a food poison. The methods to produce the toxin in large quantities and to precise specifications were pioneered at UW-Madison by Johnson and his late mentor, Ed Schantz.

Because of its incredible potency, the quality and dosages of the toxin for medical use must be carefully prepared.

The preparations made by pharmaceutical companies, says Johnson, actually contain very little toxin. To ensure that batches of the agent are of the correct therapeutic dose and of uniform quality, they are tested by injecting mice at a specified dosage that kills half of all mice exposed to the toxin.

"The mouse assay has many drawbacks and hundreds of thousands of mice are used for this every year," Pellett explains. "The most important result of this study is the high sensitivity of the assay, greater than the mouse bioassay, which is required for quality control."

The pharmaceutical industry, Johnson adds, is under pressure from the FDA to develop alternatives to the mouse. One cell-based assay has already been developed by Allergan, the company that makes BOTOX, the most famous trade name for . However, the details of that assay have not been made available.

"The assay we developed is another cell based assay," notes Pellett, "one that uses normal human neurons derived from induced , and which can be optimized for any pharmaceutical botulinum neurotoxin product."

Explore further: Heaven scent: Finding may help restore fragrance to roses

More information: toxsci.oxfordjournals.org/

Related Stories

New insights about Botulinum toxin A

Dec 02, 2010

A new study by researchers at the Faculty of Kinesiology, University of Calgary, is raising questions about the therapeutic use of botulinum toxin A.

Foodborne Staph Toxin Pinpointed by New Assay

Dec 15, 2009

(PhysOrg.com) -- Most people need about two days to recover from being sickened by foods contaminated with what's known as staphylococcal enterotoxin A, or "SEA." Produced by Staphylococcus aureus bacteria, ...

Recommended for you

Study on pesticides in lab rat feed causes a stir

Jul 02, 2015

French scientists published evidence Thursday of pesticide contamination of lab rat feed which they said discredited historic toxicity studies, though commentators questioned the analysis.

International consortium to study plant fertility evolution

Jul 02, 2015

Mark Johnson, associate professor of biology, has joined a consortium of seven other researchers in four European countries to develop the fullest understanding yet of how fertilization evolved in flowering plants. The research, ...

Making the biofuels process safer for microbes

Jul 02, 2015

A team of investigators at the University of Wisconsin-Madison and Michigan State University have created a process for making the work environment less toxic—literally—for the organisms that do the heavy ...

Why GM food is so hard to sell to a wary public

Jul 02, 2015

Whether commanding the attention of rock star Neil Young or apparently being supported by the former head of Greenpeace, genetically modified food is almost always in the news – and often in a negative ...

The hidden treasure in RNA-seq

Jul 01, 2015

Michael Stadler and his team at the Friedrich Miescher institute for Biomedical Research (FMI) have developed a novel computational approach to analyze RNA-seq data. By comparing intronic and exonic RNA reads, ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.